Drugs Made In America Acquisition Corp.
DMAA- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.
Holders of 5% or more of DMAA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Drugs Made In America Acquisition Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | 13D | 12.50%4.19M shares | New | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Karpus Management, Inc. | 13G/A | 10.33%2.51M shares | +2.14 ppfrom 8.19% | May 14, 20253 filings | Aug 14, 2026 | SEC |
| Mizuho Financial Group Inc | 13G/A | 8.50%2.06M shares | +2.50 ppfrom 6.00% | May 14, 20262 filings | Aug 13, 2026 | SEC |
| Polar Asset Management Partners Inc. | 13G | 5.70%1.90M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
| Feis Equities LLC | 13G | 5.08%1.23M shares | New | Jun 26, 20261 filing | Jun 26, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on Drugs Made In America Acquisition Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:00 PM ET | Karpus Management, Inc. | 13G/A | 10.33%2.51M shares | +2.14 ppfrom 8.19% | Jun 30, 2026 | SEC |
| Aug 14, 202611:56 AM ET | Vivaldi Asset Management, LLCand 3 others | 13G/A | 3.24%786.5K shares | −2.93 ppfrom 6.17%Below 5% | Jun 30, 2026 | SEC |
| Aug 13, 20265:12 PM ET | Glazer Capital, LLCand 1 other | 13G/A | 4.12%999.9K shares | −1.32 ppfrom 5.44%Below 5% | Jun 30, 2026 | SEC |
| Aug 13, 20266:43 AM ET | Mizuho Financial Group Inc | 13G/A | 8.50%2.06M shares | +2.50 ppfrom 6.00% | Jun 30, 2026 | SEC |
| Jun 26, 20267:56 AM ET | Feis Equities LLCand 1 other | 13G | 5.08%1.23M shares | New | Jun 18, 2026 | SEC |
| May 14, 20266:32 AM ET | Mizuho Financial Group Inc | 13G | 6.00%2.00M shares | New | Mar 31, 2026 | SEC |
| Nov 12, 20253:44 PM ET | Hudson Bay Capital Management LPand 1 other | 13G/A | 4.62%1.55M shares | −0.75 ppfrom 5.37%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20254:05 PM ET | Karpus Management, Inc. | 13G/A | 8.19%2.74M shares | +1.26 ppfrom 6.93% | Jun 30, 2025 | SEC |
| May 15, 20255:24 PM ET | Vivaldi Asset Management, LLCand 3 others | 13G | 6.17%2.07M shares | New | Mar 31, 2025 | SEC |
| May 15, 20254:17 PM ET | Glazer Capital, LLCand 1 other | 13G | 5.44%1.82M shares | New | Mar 31, 2025 | SEC |
| May 15, 20257:12 AM ET | Polar Asset Management Partners Inc. | 13G | 5.70%1.90M shares | New | Mar 31, 2025 | SEC |
| May 14, 20254:04 PM ET | Karpus Management, Inc. | 13G | 6.93%2.32M shares | New | Mar 31, 2025 | SEC |
| May 14, 20251:37 PM ET | Hudson Bay Capital Management LPand 1 other | 13G | 5.37%1.80M shares | New | Mar 31, 2025 | SEC |
| Mar 3, 20256:37 PM ET | Drugs Made In America Acquisition LLCand 1 other | 13D | 12.50%4.19M shares | New | Feb 18, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Drugs Made In America Acquisition Corp. shares.
No Form 144 notices for Drugs Made In America Acquisition Corp. are on file.